Peruzzi W T, Skoutelis A, Shapiro B A, Murphy R M, Currie D L, Cane R D, Noskin G A, Phair J P
Department of Anesthesia, Northwestern University Medical School, Chicago, IL.
Crit Care Med. 1991 Jul;19(7):892-900. doi: 10.1097/00003246-199107000-00012.
To define our ICU experience with AIDS patients, Pneumocystis carinii pneumonia, and respiratory failure, and to delineate factors predictive of hospital survival.
A retrospective study in which logistic regression analysis was applied to data obtained during the first 144 hrs of ICU admission.
A university hospital medical ICU associated with a national AIDS treatment center.
Twenty-seven male patients with AIDS, P. carinii pneumonia, and respiratory failure who desired full supportive and resuscitative care.
Of 27 patients who met study criteria, 19 (70%) were nonsurvivors and eight (30%) were survivors. The relative risk of death was 2.2 times greater in patients who exhibited the combination of pH less than 7.35 and a base deficit greater than 4 mEq/L, at any time in their ICU course, than in patients who did not (95% confidence interval = 1.01, 4.81). Furthermore, the relative risk of death was 3.7 times greater in patients who required positive end-expiratory pressure greater than 10 cm H2O after 96 hrs of ICU care than in those patients who did not (95% confidence interval = 1.09, 12.33). Indices of oxygen transfer, severity of chest radiograph abnormalities, concurrent lung infections, and most laboratory studies on hospital admission were not different between the two groups nor predictive of hospital survival.
When dealing with AIDS/P. carinii pneumonia/ICU patients, it is not possible to distinguish who will survive to hospital discharge based on information routinely available before ICU admission. Those patients with the greatest chance of survival demonstrate a significant decrease in the required level of respiratory support within the first 4 days of ICU care. The presence of a metabolic acidemia (pH less than 7.35 and base deficit greater than 4 mEq/L), at any time during the ICU course, is a poor prognostic sign. We suggest that such objective variables should be included in the development of any new outcome predictor model for this group of ICU patients.
明确我们在重症监护病房(ICU)对艾滋病患者、卡氏肺孢子虫肺炎及呼吸衰竭的治疗经验,并确定预测患者住院生存率的因素。
一项回顾性研究,对入住ICU最初144小时内获取的数据进行逻辑回归分析。
一所与国家艾滋病治疗中心相关的大学医院医学重症监护病房。
27名患有艾滋病、卡氏肺孢子虫肺炎及呼吸衰竭且希望获得全面支持和复苏治疗的男性患者。
符合研究标准的27名患者中,19名(70%)死亡,8名(30%)存活。在ICU治疗过程中的任何时间,pH值低于7.35且碱缺失大于4 mEq/L的患者,其死亡相对风险比未出现此情况的患者高2.2倍(95%置信区间 = 1.01, 4.81)。此外,在ICU治疗96小时后需要呼气末正压大于10 cm H₂O的患者,其死亡相对风险比不需要的患者高3.7倍(95%置信区间 = 1.09, 12.33)。两组患者的氧转运指标、胸部X线异常严重程度、并发肺部感染情况以及入院时的大多数实验室检查结果并无差异,也不能预测住院生存率。
在治疗艾滋病/卡氏肺孢子虫肺炎/ICU患者时,根据ICU入院前常规可得信息无法区分哪些患者能够存活至出院。存活几率最大的患者在ICU治疗的前4天内所需呼吸支持水平显著降低。在ICU治疗过程中的任何时间出现代谢性酸血症(pH值低于7.35且碱缺失大于4 mEq/L)是预后不良的迹象。我们建议,在为这类ICU患者开发任何新的预后预测模型时,应纳入此类客观变量。